NASDAQ:EXPO - Exponent Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$56.95 -0.44 (-0.77 %)
(As of 03/20/2019 03:59 PM ET)
Previous Close$57.39
Today's Range$56.90 - $57.95
52-Week Range$38.17 - $58.29
Volume114,073 shs
Average Volume187,415 shs
Market Capitalization$2.93 billion
P/E Ratio45.56
Dividend Yield1.12%
Beta0.47
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryResearch & Consulting Services
SectorBusiness Services
Current SymbolNASDAQ:EXPO
CUSIP30214U10
Phone650-326-9400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$379.52 million
Cash Flow$1.4198 per share
Book Value$6.04 per share

Profitability

Net Income$72.25 million

Miscellaneous

Employees1,122
Market Cap$2.93 billion
Next Earnings Date4/18/2019 (Estimated)
OptionableOptionable

Exponent (NASDAQ:EXPO) Frequently Asked Questions

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent announced a quarterly dividend on Friday, February 1st. Investors of record on Friday, March 8th will be given a dividend of $0.16 per share on Friday, March 22nd. This represents a $0.64 annualized dividend and a yield of 1.12%. The ex-dividend date of this dividend is Thursday, March 7th. This is an increase from Exponent's previous quarterly dividend of $0.13. View Exponent's Dividend History.

When did Exponent's stock split? How did Exponent's stock split work?

Exponent shares split on the morning of Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were payable to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) issued its quarterly earnings results on Thursday, January, 31st. The business services provider reported $0.30 EPS for the quarter, topping the consensus estimate of $0.29 by $0.01. The business services provider earned $85.27 million during the quarter, compared to analyst estimates of $88.21 million. Exponent had a net margin of 19.04% and a return on equity of 21.53%. View Exponent's Earnings History.

When is Exponent's next earnings date?

Exponent is scheduled to release their next quarterly earnings announcement on Thursday, April 18th 2019. View Earnings Estimates for Exponent.

What price target have analysts set for EXPO?

3 brokers have issued 1-year price objectives for Exponent's shares. Their forecasts range from $56.00 to $56.00. On average, they expect Exponent's stock price to reach $56.00 in the next twelve months. This suggests that the stock has a possible downside of 1.7%. View Analyst Price Targets for Exponent.

What is the consensus analysts' recommendation for Exponent?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Exponent.

What are Wall Street analysts saying about Exponent stock?

Here are some recent quotes from research analysts about Exponent stock:
  • 1. According to Zacks Investment Research, "Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. " (2/5/2019)
  • 2. Cantor Fitzgerald analysts commented, ": We maintain our Overweight rating on Exponent and our PT of $56. We believe the nature of the company’s business gives Exponent an advantage in its ability to deliver results regardless of the economic backdrop. The company reported low-single-digit revenue growth for 4Q18, slightly below expectations. We expect revenues to grow in the mid-to-high single-digit range for all of 2019, with the opportunity for upside to conservative guidance, in our opinion, as we believe catalysts exist in a number of areas." (2/1/2019)

Has Exponent been receiving favorable news coverage?

News headlines about EXPO stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Exponent earned a media sentiment score of 0.7 on InfoTrie's scale. They also gave news articles about the business services provider a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an impact on the stock's share price in the near term.

Who are some of Exponent's key competitors?

What other stocks do shareholders of Exponent own?

Who are Exponent's key executives?

Exponent's management team includes the folowing people:
  • Dr. Paul R. Johnston, Exec. Chairman (Age 65)
  • Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 50)
  • Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 53)
  • Dr. Harri K. Kytomaa, Group VP of Engineering Sciences & Principal Engineer (Age 60)
  • Dr. Steven J. Murray, Group VP of Mechanics & Materials and Principal Engineer (Age 44)

Who are Exponent's major shareholders?

Exponent's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.42%), Conestoga Capital Advisors LLC (4.44%), Dimensional Fund Advisors LP (3.29%), Atlanta Capital Management Co. L L C (1.85%), GW&K Investment Management LLC (1.79%) and Northern Trust Corp (1.73%). Company insiders that own Exponent stock include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss and Sally Shepard. View Institutional Ownership Trends for Exponent.

Which major investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, WINTON GROUP Ltd, Atlanta Capital Management Co. L L C, GW&K Investment Management LLC, Public Employees Retirement Association of Colorado, PNC Financial Services Group Inc., Bank of New York Mellon Corp and Barclays PLC. Company insiders that have sold Exponent company stock in the last year include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Richard L Schlenker Jr and Richard Reiss. View Insider Buying and Selling for Exponent.

Which major investors are buying Exponent stock?

EXPO stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Mackenzie Financial Corp, Conestoga Capital Advisors LLC, Geode Capital Management LLC, Geode Capital Management LLC, 361 Capital LLC, Royce & Associates LP and Robeco Institutional Asset Management B.V.. View Insider Buying and Selling for Exponent.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $56.95.

How big of a company is Exponent?

Exponent has a market capitalization of $2.93 billion and generates $379.52 million in revenue each year. The business services provider earns $72.25 million in net income (profit) each year or $1.25 on an earnings per share basis. Exponent employs 1,122 workers across the globe.

What is Exponent's official website?

The official website for Exponent is http://www.exponent.com.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]


MarketBeat Community Rating for Exponent (NASDAQ EXPO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  204 (Vote Outperform)
Underperform Votes:  203 (Vote Underperform)
Total Votes:  407
MarketBeat's community ratings are surveys of what our community members think about Exponent and other stocks. Vote "Outperform" if you believe EXPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel